长生生物董事长被刑拘

China has placed in criminal detention the chairwoman of Changchun Changsheng Life Sciences Ltd, a vaccine maker accused of falsifying data, and 14 others involved in the case, police said yesterday.

警方于昨日表示，已将涉嫌伪造数据的疫苗生产商长春长生生命科学有限公司董事长及其他14名涉案人员进行了刑事拘留。

“The Changchun new district public security bureau has detained 15 people, including the chairwoman and others, who are involved in the Changsheng case,” the bureau said in a statement.

长春新区公安局在一份声明中谈到，长春市新区公安局已经拘留了包括女董事长和其他涉案人员在内的15名犯罪嫌疑人。

Meanwhile, the discipline inspection body of the Communist Party of China Jilin provincial committee and the supervisory commission of the provincial government have ordered an investigation into the case and pledged serious punishment to those found responsible.

同时，中国共产党中央纪律检查机构和省政府监察委员会已经下令调查此案，并对责任人进行严厉的处罚。

The two watchdogs are reviewing information and public complaints regarding the company and its key personnel. They also ordered an investigation into possible dereliction of duty among food and drug officials, and vowed stern punishment for those involved. A work team has been established to investigate potential corruption during the company’s restructuring, production, and operation processes.

这两家监管机构正在审查该公司及其关键人员的信息和公众投诉。他们也下令对食品和药品官员可能的玩忽职守进行调查，并发誓要严惩涉案人员。并且他们已经成立了一个工作小组来调查公司重组、生产和运营过中潜在的腐败问题。

Xu Jinghe, vice minister of the China Food and Drug Administration, said they discovered that the company had fabricated production records and product inspection records, and arbitrarily changed process parameters and equipment during its production of freeze-dried human rabies vaccines.

中国食品药品监督管理局副局长徐金和表示，他们发现该公司伪造了生产及产品检验记录，并在生产用于人类的冻干狂犬病疫苗期间任意更改工艺参数和设备。

The CFDA revoked the company’s drug GMP certificate. The firm was also found to have sold 252,600 doses of ineffective DPT vaccines.

中国食品药品监督总局撤销了该公司的药品生产质量管理规范认证。该公司已经售出了252,600剂无效的百白破疫苗。